e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine (General)

Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer

Hiroaki Kuroda; Junji Ichinose; Katsuhiro Masago; Yusuke Takahashi; Takeo Nakada; Masayuki Nakao; Sakae Okumura; Kohei Hashimoto · 2021 · Medicina

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Background and Objectives : Lobe-specific nodal dissection (L-SND) is currently acceptable for the dissection of early-stage non-small cell lung cancer (NSCLC) but not for cancers of more advanced clinical stages. We aimed to assess the efficacy of L-SND, compared to systemic nodal dissection (SND). Materials and Methods : We retrospectively collected the clinical data of patients with carcinoembryonic antigen (CEA) abnormality who underwent complete resection of NSCLC via lobectomy or more in addition to either SND or L-SND at two cancer-specific institutions from January 2006 to December 201

Abstract by Hiroaki Kuroda; Junji Ichinose; Katsuhiro Masago; Yusuke Takahashi; Takeo Nakada; Masayuki Nakao; Sakae Okumura; Kohei Hashimoto, Medicina (2021) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3390/medicina57121365